Execution is naturally key, but by that time it'll be derisked...

Execution is naturally key, but by that time it'll be derisked even more, many multiples higher and investors would miss out on accumulating a considerable cheap position. Even if you choose to ignore Richard White, Paul Wiltshire or Ken Gaunts recent positions, or our two high credential songtradr N.E.Ds, one cannot ignore how rare it is to see whales investing together into a listed speccy, or, the rare pedigree of our Board under 100m MC.

Normally it'll just stay unlisted/private equity until they are ready to an IPO at a higher price (like what songtradr is doing with their company). Gives me alot of confidence that unlike other micros, we have a wealth of opportunities (pun intended) unavailable to other companies. Execution of revenue growth and clearer proof of the path to profitability is the last risk that needs to be removed before we can comfortably begin to forecast possible mid cap targets.

Have you been here since 2020? I think that's where most of us slowly began create a position on dips as it derisked (obviously abit too early until 2022 tbh).

The recipe to success is continuing to unveil itself since songtradr took the helm a year ago.